#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Marginal zone lymphoma recurrent Angiosarcoma recurrent Gastrointestinal neuroendocrine tumour Liposarcoma metastatic Cervix carcinoma Pleomorphic liposarcoma Myasthenia gravis Hypochromic anaemia Barth syndrome Bronchopulmonary dysplasia Inclusion body myositis Rheumatoid arthritis KBG syndrome Transplant rejection Osteochondrodysplasia More trials…

    Learn about Rare Diseases

    Thrombotic thrombocytopenic purpura – Trials in Disease Uterine leiomyosarcoma – Diagnostics Mantle cell lymphoma refractory – Life with Disease VEXAS syndrome – Basic Information KBG syndrome Wolfram syndrome – Life with Disease Hepatic angiosarcoma Factor VIII deficiency – Treatment Castleman’s disease – Diagnostics Atypical teratoid/rhabdoid tumour of CNS – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mebufotenin Rifapentine Ascorbic Acid Bp Pegipanermin Human Albumin Solution Tiemonium Methylsulphate Zipalertinib Andexanet Alfa Other Blood Products For-6219 Ibuprofen Arginine Acetylsalicylic Acid Ph. Eur. Bms-986408 Concizumab Metolazone PARECOXIB Levomepromazine Hydrochloride Fluocinolone Acetonide Sodium Citrate Hyoscine Butylbromide More therapies…

    Learn about Your Condition

    Schizoaffective disorder Neuropathy peripheral Oesophageal adenocarcinoma Blood iron increased Exposure via breast milk Hyperhidrosis Hodgkin's disease recurrent Exudative retinopathy Metastasis Dry mouth Ovarian cancer stage III Cold urticaria Muscle hypertrophy Indolent systemic mastocytosis Pyoderma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Polycystic ovarian syndrome

  • Study on Tirzepatide for Women with Overweight or Obesity and Polycystic Ovary Syndrome (PCOS)

    Recruiting

    3 1 1
    Investigated Diseases:
    • Obesity
    • Overweight
    • Polycystic ovarian syndrome
    Investigated Drugs:
    • Dydrogesterone
    • Glucose
    • Medroxyprogesterone Acetate
    Germany

  • Study on Acupuncture and Metformin for Improving Insulin Sensitivity in Women with Polycystic Ovary Syndrome

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Polycystic ovarian syndrome
    Investigated Drugs:
    • Metformin Hydrochloride
    Sweden

  • Study on Letrozole and Gonadotropins for Women with Polycystic Ovary Syndrome (PCOS) to Improve Live Birth Rates

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Polycystic ovarian syndrome
    Investigated Drugs:
    • Follitropin Alfa
    • HUMAN MENOPAUSAL GONADOTROPHINS
    • Letrozole
    The Netherlands

  • Study on Pregnancy Rates in Women with Polycystic Ovary Syndrome Using Letrozole and Gonadotropins

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Polycystic ovarian syndrome
    Investigated Drugs:
    • Follitropin Alfa (Genetical Recombination)
    • Follitropin Beta
    • Follitropin Alfa
    Spain

  • Study on Metformin and Metformin Hydrochloride for Overweight Adults with Polycystic Ovary Syndrome

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Polycystic ovarian syndrome
    Investigated Drugs:
    • Metformin Hydrochloride
    • Metformin
    Finland

  • Study on the Effects of Spironolactone, Pioglitazone, and Metformin for Adolescent Girls and Young Women with Polycystic Ovary Syndrome (PCOS)

    Not recruiting

    2 1
    Investigated Drugs:
    • Pioglitazone
    • Metformin
    • Spironolactone
    Austria Denmark Italy Norway Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!